Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Type 1 Diabetes
NCT04124211Unknown
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label, single-arm trial of fecal microbiome transplant in type 1 diabetes mellitus (T1D), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoints: Mean Amplitude of Glycemic Excursion at 24 weeks, Standard Deviation of Blood Glucose at 24 weeks and 2 more. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04124211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124211.